Sunto-gun, Japan

Noriaki Uesaka

USPTO Granted Patents = 11 


 

Average Co-Inventor Count = 4.9

ph-index = 4

Forward Citations = 48(Granted Patents)


Location History:

  • Sunto-gun, JP (2010 - 2014)
  • Tokyo, JP (2017)
  • Shizuoka, JP (2015 - 2019)

Company Filing History:


Years Active: 2010-2019

Loading Chart...
Loading Chart...
Loading Chart...
11 patents (USPTO):Explore Patents

Title: Noriaki Uesaka: Innovator in Therapeutic Agents for Motor Disorders

Introduction

Noriaki Uesaka is a prominent inventor based in Sunto-gun, Japan. He has made significant contributions to the field of therapeutic agents, particularly for motor disorders. With a total of 11 patents to his name, Uesaka's work is recognized for its innovative approach to treating various movement disorders.

Latest Patents

Uesaka's latest patents focus on therapeutic agents for motor disorders. These agents are designed for the treatment and/or prophylaxis of movement disorders such as extrapyramidal syndrome, bradykinesia, gait disturbance, dystonia, dyskinesia, and tardive dyskinesia. His formulations include thiazole derivatives as active ingredients, which are aimed at alleviating the side effects of L-DOPA and dopamine agonist therapy.

Career Highlights

Noriaki Uesaka is currently associated with Kyowa Hakko Kirin Co., Limited, where he continues to advance his research and development efforts. His work has garnered attention for its potential impact on improving the quality of life for individuals suffering from motor disorders.

Collaborations

Uesaka collaborates with notable colleagues such as Takashi Sawada and Masamori Sugawara. Their combined expertise contributes to the innovative research and development of therapeutic agents in the field.

Conclusion

Noriaki Uesaka's contributions to the field of therapeutic agents for motor disorders highlight his dedication to innovation and improvement in medical treatments. His ongoing work promises to make a significant impact on the lives of those affected by movement disorders.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…